Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances
02 déc. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Simulator Version 21, which updates the...
Certara Announces Update of D360™ Scientific Informatics Software
29 nov. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of D360 version 21.5, an industry-leading scientific...
Certara Announces Closing of Public Offering of Common Stock
22 nov. 2021 17h45 HE
|
Certara
PRINCETON, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000...
Certara Announces Pricing of Public Offering of Common Stock
17 nov. 2021 23h27 HE
|
Certara
PRINCETON, N.J., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million...
Certara Announces Proposed Public Offering of Common Stock
15 nov. 2021 17h30 HE
|
Certara
PRINCETON, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering by certain selling...
Certara Reports Third Quarter 2021 Financial Results
09 nov. 2021 16h10 HE
|
Certara
PRINCETON, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the third quarter of fiscal year 2021. ...
Certara Appoints James E. Cashman III as Chairman of Board of Directors
08 nov. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that James E. Cashman III, a current Board member, will be...
Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
03 nov. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William F. Feehery, Chief Executive Officer, and Andrew...
Pinnacle 21 Awarded FDA Contract for 5 Years for Software and Services
28 oct. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has awarded a...
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award
25 oct. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that its Simcyp COVID-19 Vaccine Model has won an R&D 100...